Introduction
The Parsortix® system gives translational researchers the power to capture and harvest circulating tumour and other cells of interest from 100 μL to 40 mL blood samples, providing greater flexibility in downstream analysis.
The Parsortix system addresses the need for:
*Highly enriched cell populations
*Epitope independence, agnostic to cell phenotype
*Research flexibility
*Viable cells
*CTC clusters
*Simple, easy process
Features / strengths
1. Microfluidic chip
2. Direct capture without sample pre-processing
3. No need for magnetic beads and antibodies
4. Live cells/can be used for comprehensive analysis
5. Sample volume 100ul-40ml
Specification in detail
Supporting document
